Y‐27632 Suppresses the Growth and Migration of Oral Squamous Cell Carcinoma, but Upregulates Autophagy by Suppressing mTOR Effectors
Journal of Oral Pathology & Medicine · 2025
DOI: 10.1111/jop.13603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2025. Verfasst von Jie Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Amides, Pyridines, Cell Movement, Mouth Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Medical and Health Science and Technology Development Project of Shandong Province, National College Students Innovation and Entrepreneurship Training Program.
Abstract (Originalsprache)
Background
The Rho‐associated protein kinase (ROCK) inhibitor Y‐27632 is a potential immunotherapeutic agent for cancer treatment. Y‐27632 blocks the growth and migration of oral squamous cell carcinoma (OSCC) CAL‐27 cells. However, detailed studies on the underlying mechanisms have not yet been reported.
Methods
We investigated the effects of Y‐27632 on the proliferation, migration, and invasion of OSCC cells (CAL‐27, SCC‐4, and SCC‐9) using the Cell Counting Kit‐8 assay, ethynyl‐2′‐deoxyuridine staining, cell scratch, and transwell assay in vitro. Next, ROCK1/2 was knocked down using siRNA to confirm that the effects of Y‐27632 were mediated by the inhibition of ROCK activity. A xenograft mouse model was used to verify the effects of Y‐27632 in vivo. The mechanisms underlying Y‐27632‐induced tumor suppression were detected using western blotting and qRT‐PCR.
Results
Our data demonstrated that Y‐27632 potently inhibited OSCC cells (CAL‐27, SCC‐4, and SCC‐9) by inhibiting ROCK activity. In vivo assays confirmed that Y‐27632 suppressed OSCC growth by reducing cell proliferation. Biochemical assays demonstrated that Y‐27632 inactivated the AKT pathway, and treatment with SC79, an AKT activator, rescued the cell growth and migration inhibition elicited by Y‐27632. Further investigation revealed that Y‐27632 enhanced autophagy by suppressing the AKT/mTOR pathway.
Conclusion
Our study demonstrated that Y‐27632 significantly suppressed the growth and migration of OSCC cells and upregulated autophagy via the AKT/mTOR pathway, thus providing a potential therapeutic drug for patients with OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- School of Stomatology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
- Department of Stomatology, Affiliated Hospital of Heze Medical College, Heze, Shandong, China.
- Department of Periodontology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
ORCID-Profile: Jie Wen
Förderung
- Medical and Health Science and Technology Development Project of Shandong Province
- National College Students Innovation and Entrepreneurship Training Program
Zitieren
APA
Wen, J., Sun, Y., Ma, L., Zu, T., Wang, N., Zhang, T., Liang, J., Zhang, Y., Lu, H., Wu, Y., & Zhang, S. (2025). Y‐27632 Suppresses the Growth and Migration of Oral Squamous Cell Carcinoma, but Upregulates Autophagy by Suppressing mTOR Effectors. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13603
Vancouver
Wen J, Sun Y, Ma L, Zu T, Wang N, Zhang T, et al. Y‐27632 Suppresses the Growth and Migration of Oral Squamous Cell Carcinoma, but Upregulates Autophagy by Suppressing mTOR Effectors. Journal of Oral Pathology & Medicine. 2025. doi:10.1111/jop.13603
BibTeX
@article{Wen2025,
author = {Wen, Jie and Sun, Yunhan and Ma, Li and Zu, Tingjian and Wang, Na and Zhang, Tianqi and Liang, Jin and Zhang, Yulei and Lu, Haoyang and Wu, Yihua and Zhang, Shizhou},
title = {Y‐27632 Suppresses the Growth and Migration of Oral Squamous Cell Carcinoma, but Upregulates Autophagy by Suppressing mTOR Effectors},
journal = {Journal of Oral Pathology & Medicine},
year = {2025},
doi = {10.1111/jop.13603}
}
EUVIMED